Always good to review the product and time-line. I agree that there will be a lull now before all these projects are on their way to completion and revenue from sales start to flow. Anibidiol (launched in Switzerland in Nov. 17) and Cannaqix will, IMO, not be an avalanche at first. This is a small country, (approx. 8,5 million) and may not have the impact of much larger markets. The Swiss Quality stamp is a good brand and what is the saying: from little acorns big trees grow.
- Forums
- ASX - By Stock
- CPH
- not positive outlook
not positive outlook, page-139
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)